Evaluating the sensitivity, reproducibility and flexibility of a method to test hard shell capsules intended for use in dry powder inhalers

被引:12
作者
Chong, Rosalind H. E. [1 ]
Jones, Brian E. [1 ,2 ]
Diez, Fernando [2 ]
Birchall, James C. [1 ]
Coulman, Sion A. [1 ]
机构
[1] Cardiff Univ, Cardiff Sch Pharm & Pharmaceut Sci, Cardiff CF10 3NB, S Glam, Wales
[2] Qualicaps Europe SAU, Alcobendas, Madrid, Spain
关键词
Capsule; Hypromellose; Gelatin; Dry powder inhaler; Quality Assurance; Puncture; PERFORMANCE; DELIVERY; GELATIN; DESIGN;
D O I
10.1016/j.ijpharm.2016.01.034
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Pharmaceutical tests for hard shell capsules are designed for orally administered capsules. The use of capsules in dry powder inhalers is widespread and increasing and therefore more appropriate tests are required to ensure quality and determine if these capsules are fit for purpose. This study aims to determine the flexibility, reproducibility and sensitivity of a quantitative method that is designed to evaluate the puncture characteristics of different capsule shell formulations under different climatic conditions. A puncture testing method was used to generate force displacement curves for five capsule formulations that were stored and tested at two different temperatures (5 degrees C and 19 degrees C). Force-displacement puncture profiles were reproducible for individual capsule shell formulations. The methodology was able to discriminate between capsules produced using different primary materials i.e. gelatin versus hypromellose, as well as more minor changes to capsule formulation i.e. different material grades and excipients. Reduced temperature increased the forces required for capsule puncture however further work is required to confirm its significance. Results indicate the method provides a reproducible and sensitive means of evaluating capsule puncture. Future studies should validate the methodology at different test sites, using different operators and with different capsule shell formulations. (C) 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license.
引用
收藏
页码:316 / 325
页数:10
相关论文
共 16 条
[1]  
Atkins Paul J, 2005, Respir Care, V50, P1304
[2]  
Birchall JC, 2008, DRUG DEV IND PHARM, V34, P870, DOI [10.1080/03639040801928903, 10.1080/03639040801928903 ]
[3]   The role of capsule on the performance of a dry powder inhaler using computational and experimental analyses [J].
Coates, MS ;
Fletcher, DF ;
Chan, HK ;
Raper, JA .
PHARMACEUTICAL RESEARCH, 2005, 22 (06) :923-932
[4]  
Council of Europe-European Directorate for the Quality of Medicines (EDQM), 2005, EUR PHARM 5 0, P50
[5]   Developing an efficient and reliable dry powder inhaler for pulmonary drug delivery - A review for multidisciplinary researchers [J].
Islam, Nazrul ;
Cleary, Matthew J. .
MEDICAL ENGINEERING & PHYSICS, 2012, 34 (04) :409-427
[6]  
Jones B., 2003, DRUG DELIV TECHNOL, V3, P2
[7]  
Jones B. E., 2004, Pharmaceutical capsules, P79
[8]   Time domain 1H NMR as a new method to monitor softening of gelatin and HPMC capsule shells [J].
Kuentz, Martin ;
Rothenhauesler, Benno ;
Roethlisberg, Dieter .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2006, 32 (10) :1165-1173
[9]   "Pierce and inhale" design in capsule based dry powder inhalers: Effect of capsule piercing and motion on aerodynamic performance of drugs [J].
Martinelli, Francesco ;
Balducci, Anna Giulia ;
Rossi, Alessandra ;
Sonvico, Fabio ;
Colombo, Paolo ;
Buttini, Francesca .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2015, 487 (1-2) :197-204
[10]  
Nagata S., 2002, DRUG DELIVERY TECHNO, V2, P34